# Initial data from Foundayo's launch is lagging Novo Nordisk's oral Wegovy, which hit the market in January.

*biotech · news · 2026-04-29 · Reuters*

## Key points

- Indian drugmakers began selling cheaper generic versions of Novo's injectable Wegovy last month.
- Canada approved its first generic version of Novo's Ozempic for diabetes and weight loss use.
- Lilly raised the UK list price of Mounjaro by up to 170% last year.
- Direct-to-consumer sales data may not be reflected in initial launch numbers for Foundayo.

**Companies:** Lilly, Novo Nordisk
**Countries:** India, Canada, United States, United Kingdom, Brazil, China

[Read the full story on Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-investors-are-eager-foundayo-insight-after-early-launch-data-2026-04-29/)

---

Canonical: https://newsio.io/n/3ced900f-031c-454a-88d5-75bef400d921/initial-data-from-foundayos-launch-is-lagging-novo-nordisks-oral-wegovy-which-hi
Summarized by Newsio from Reuters. https://newsio.io/how-it-works